In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
This study aims to validate that PLGF is a biomarker of cerebral lesions and therefore of secondary developmental disorders and disabilities that will be best diagnosed at 2 and 6 years of age.
∙ Mother:
• Pregnant woman (monofetal or twin pregnancy, whatever the parity)
• Age\> or = to 18 years
• Person affiliated to a social security system
• Person who read and understood the information form and signed the consent form
‣ Alcohol exposure group Chronic consumption of at least 30 g of alcohol per week or acute consumption of binge drinking type during pregnancy (knowing that a unit of 10 g of pure alcohol corresponds to 25 cl of beer 4 ° 5, 10 cl of wine at 12 °, 3 cl of whiskey, 7 cl of Porto ...)
⁃ Control group No alcohol consumption during pregnancy
⁃ Child Informed parents and written consent signed by the father and mother for the child's participation in this research (unless one of the parents does not have parental authority)